In the application segment, Natural Ellagic Acid segmentation reveals distinct demand drivers. The pharmaceutical sector, leveraging ellagic acid’s antioxidant and anti‑inflammatory properties for drug development, dominates with an estimated 45% share, reflecting high R&D spend and regulatory approvals. The nutraceutical arena, encompassing dietary supplements and functional foods, follows at 35%, buoyed by consumer health trends and the compound’s perceived longevity benefits. Cosmetics applications, focused on anti‑aging and skin‑brightening formulations, represent 15% of usage, driven by premium skincare product launches. The food & beverage category, where ellagic acid is used as a natural preservative or functional ingredient, remains the smallest at 5%, constrained by formulation challenges and cost sensitivity. This application‑centric breakdown underscores how each end‑use contributes proportionally to the overall market valuation and guides strategic allocation of resources across development, marketing, and compliance activities.